Joint Estimation of Remission and Response for Methotrexate‐Based DMARD Options in Rheumatoid Arthritis: A Bivariate Network Meta‐Analysis

OBJECTIVE: To jointly estimate American College of Rheumatology (ACR50) response (a more commonly reported outcome) and remission (a more clinically relevant outcome) for methotrexate (MTX)‐based treatment options in rheumatoid arthritis (RA). METHODS: We conducted a bivariate network meta‐analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Pokharel, Gyanendra, Deardon, Rob, Barnabe, Cheryl, Bykerk, Vivian, Bartlett, Susan J, Bessette, Louis, Boire, Gilles, Hitchon, Carol A, Keystone, Edward, Pope, Janet, Schieir, Orit, Tin, Diane, Thorne, Carter, Hazlewood, Glen S, Baron, Murray, Colmegna, Ines, Fallavollita, Sabrina, Haaland, Derek, Haraoui, Paul, Hazlewood, Glen, Hitchon, Carol, Jamal, Shahin, Joshi, Raman, Keystone, Ed, Nair, Bindu, Panopoulos, Peter, Penney, Christopher, Rubin, Laurence, Villeneuve, Edith, Zummer, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858043/
https://www.ncbi.nlm.nih.gov/pubmed/31777827
http://dx.doi.org/10.1002/acr2.11052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858043/
https://www.ncbi.nlm.nih.gov/pubmed/31777827
http://dx.doi.org/10.1002/acr2.11052

Ejemplares similares